UC Davis manufactures CAR T cells on-site

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

UC Davis Health has successfully treated its first patient with chimeric antigen receptor T cells created in its cellular therapy lab. UC Davis is now one of only a few medical centers in California manufacturing CAR T cells on-site. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login